Telangana has set an ambitious goal to attract investments totaling ₹1 lakh crore in the life sciences sector by 2030, as part of its strategy to establish itself as a global hub for this industry. This announcement was made by Duddilla Sridhar Babu, the state”s Minister for Industries and Information Technology, during his keynote address at the AusBiotech International Conference 2025 held in Melbourne.
During the conference, which was co-hosted by AusBiotech and the Government of Victoria, Sridhar Babu highlighted the development of a comprehensive life sciences policy aimed at boosting innovation, enhancing infrastructure, and fostering global collaborations. He encouraged Australian businesses to consider investment opportunities in high-growth areas such as cell and gene therapy, biologics, biosimilars, mRNA vaccines, contract research, diagnostics, MedTech, and digital health.
“Telangana”s strength is rooted in its innovation ecosystem. Our mission is not just to “Make in India” but to “Invent in Telangana”,” he remarked, expressing optimism that the conference would pave the way for a “Victoria–Telangana Innovation Corridor.”
Additionally, Sridhar Babu invited Australian companies to participate in the upcoming BioAsia 2026 event scheduled to take place in Hyderabad in February. He noted that the state is making significant investments to create a skilled bio-digital workforce capable of supporting the demands of emerging technologies in biotechnology, artificial intelligence, and healthcare through various initiatives.
He pointed out that Hyderabad has been recognized as a global life sciences hub, ranking alongside cities such as Boston, San Francisco, Cambridge, Beijing, and Tokyo in the Global Life Sciences Atlas 2025, marking it as the only Indian city to achieve this recognition.
